P8IP
Pier 88 Investment Partners Portfolio holdings
AUM
$538M
This Quarter Return
+0.93%
1 Year Return
+9.78%
3 Year Return
+26.16%
5 Year Return
+53.5%
10 Year Return
–
AUM
$446M
AUM Growth
+$446M
(+9.6%)
Cap. Flow
+$30.2M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
46.7%
Holding
106
New
5
Increased
56
Reduced
7
Closed
8
Top Buys
| 1 |
Coherent
COHR
|
$2.93M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$2.81M |
| 3 |
Shift4
FOUR
|
$2.07M |
| 4 |
CrowdStrike
CRWD
|
$1.62M |
| 5 |
WIX.com
WIX
|
$1.43M |
Top Sells
| 1 |
KBR
KBR
|
$1.64M |
| 2 |
Tradeweb Markets
TW
|
$1.63M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
$1.57M |
| 4 |
KKR & Co
KKR
|
$1.52M |
| 5 |
SPDR Gold Trust
GLD
|
$602K |
Sector Composition
| 1 | Technology | 9.2% |
| 2 | Healthcare | 3.25% |
| 3 | Consumer Discretionary | 2.56% |
| 4 | Industrials | 2.49% |
| 5 | Consumer Staples | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Medpace
MEDP
$13.4B
| $754K | 0.17% |
1,830
+720
| +65% | +$297K |
|
|
PETQ
52
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $719K | 0.16% |
+32,600
| New | +$719K |
|
53
Rocket Pharmaceuticals
RCKT
$354M
| $665K | 0.15% |
30,900
+12,900
| +72% | +$278K |
|
54
Krystal Biotech
KRYS
$4.27B
| $617K | 0.14% |
3,360
+2,190
| +187% | +$402K |
|
|
55
Tradeweb Markets
TW
$26.3B
| $616K | 0.14% |
5,815
-15,385
| -73% | -$1.63M |
|
56
Silicon Laboratories
SLAB
$4.41B
| $533K | 0.12% |
4,822
+1,410
| +41% | +$156K |
|
|
RCM
57
DELISTED
R1 RCM Inc. Common Stock
RCM
| $494K | 0.11% |
39,360
-7,120
| -15% | -$89.4K |
|
58
Neurocrine Biosciences
NBIX
$13.8B
| $489K | 0.11% |
3,550
+2,100
| +145% | +$289K |
|
59
AbCellera Biologics
ABCL
$1.25B
| $478K | 0.11% |
161,620
+126,640
| +362% | +$375K |
|
60
Iovance Biotherapeutics
IOVA
$807M
| $470K | 0.11% |
58,580
+35,680
| +156% | +$286K |
|
61
Absci
ABSI
$357M
| $457K | 0.1% |
148,220
+104,650
| +240% | +$322K |
|
|
62
KKR & Co
KKR
$124B
| $442K | 0.1% |
4,200
-14,400
| -77% | -$1.52M |
|
63
Helen of Troy
HELE
$564M
| $412K | 0.09% |
4,445
+2,130
| +92% | +$198K |
|
64
ATI
ATI
$10.7B
| $410K | 0.09% |
7,400
+4,900
| +196% | +$272K |
|
65
Keysight
KEYS
$28.1B
| $399K | 0.09% |
2,915
+1,900
| +187% | +$260K |
|
66
NVIDIA
NVDA
$4.24T
| $395K | 0.09% |
3,200
+860
| +37% | +$106K |
|
67
Pyxis Oncology
PYXS
$79.4M
| $376K | 0.08% |
113,700
+62,340
| +121% | +$206K |
|
68
DTE Energy
DTE
$28.4B
| $321K | 0.07% |
2,894
| – | – |
|
69
10x Genomics
TXG
$1.74B
| $253K | 0.06% |
13,000
+5,900
| +83% | +$115K |
|
70
Dominion Energy
D
$51.1B
| $211K | 0.05% |
4,315
| – | – |
|
71
Recursion Pharmaceuticals
RXRX
$2.04B
| $185K | 0.04% |
+24,700
| New | +$185K |
|
72
Revolve Group
RVLV
$1.59B
| $182K | 0.04% |
+11,470
| New | +$182K |
|
73
Equinox Gold
EQX
$6.85B
| $104K | 0.02% |
19,900
| – | – |
|
74
Five Below
FIVE
$8B
| $65.4K | 0.01% |
600
| – | – |
|
75
Adaptive Biotechnologies
ADPT
$2.01B
| – | – |
-26,415
| Closed | -$84.8K |
|